APA (7th ed.) Citation

Zeng, S., Yan, Q., Yang, L., Mei, Q., & Lu, H. Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2. Wiley.

Chicago Style (17th ed.) Citation

Zeng, Si-yu, Qiu-jiang Yan, Li Yang, Qing-hua Mei, and Hui-qin Lu. Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 Against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2. Wiley.

MLA (9th ed.) Citation

Zeng, Si-yu, et al. Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 Against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2. Wiley.